T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Viatris
VTRS
$18.5B
| $253M | 0.05% |
4,481,412
+3,865,442
| +628% | +$208M |
|
|
CLR
377
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $253M | 0.05% |
6,583,170
-1,108,411
| -14% | -$54.6M |
|
378
Lazard
LAZ
$4.24B
| $252M | 0.05% |
5,028,230
-1,914,190
| -28% | -$94.9M |
|
379
Toro Company
TTC
$9.32B
| $251M | 0.05% |
7,872,300
+1,150,040
| +17% | +$35.5M |
|
380
Tapestry
TPR
$31.1B
| $248M | 0.05% |
6,615,270
-137,400
| -2% | -$4.84M |
|
381
Texas Capital Bancshares
TCBI
$4.38B
| $243M | 0.05% |
4,475,878
+238,438
| +6% | +$13.5M |
|
|
JOY
382
DELISTED
Joy Global Inc
JOY
| $242M | 0.05% |
5,210,779
+10,700
| +0.2% | +$547K |
|
|
CSC
383
DELISTED
Computer Sciences
CSC
| $242M | 0.05% |
9,100,794
+62,196
| +0.7% | +$1.6M |
|
384
Wheaton Precious Metals
WPM
$61.3B
| $241M | 0.05% |
11,842,286
+6,357,550
| +116% | +$126M |
|
385
DexCom
DXCM
$34.3B
| $239M | 0.05% |
17,387,372
+30,172
| +0.2% | +$369K |
|
386
LyondellBasell Industries
LYB
$20.3B
| $237M | 0.05% |
2,980,335
-1,236,792
| -29% | -$107M |
|
|
BRCM
387
DELISTED
BROADCOM CORP CL-A
BRCM
| $235M | 0.05% |
5,428,185
-701,396
| -11% | -$28.7M |
|
388
Southern Copper
SCCO
$165B
| $235M | 0.05% |
9,079,232
-791,435
| -8% | -$21.1M |
|
389
Monro
MNRO
$359M
| $234M | 0.05% |
4,054,130
+105,450
| +3% | +$5.62M |
|
|
PFPT
390
DELISTED
Proofpoint, Inc.
PFPT
| $234M | 0.05% |
4,846,007
-480,040
| -9% | -$20.5M |
|
391
Campbell Soup
CPB
$6.74B
| $232M | 0.05% |
5,274,938
-3,317,290
| -39% | -$145M |
|
392
Autodesk
ADSK
$52.7B
| $232M | 0.05% |
3,860,584
-4,423,808
| -53% | -$256M |
|
|
HOLX
393
DELISTED
Hologic
HOLX
| $231M | 0.05% |
8,634,311
+1,916,080
| +29% | +$49.5M |
|
394
eBay
EBAY
$45.5B
| $229M | 0.05% |
9,709,659
+3,686,720
| +61% | +$83.7M |
|
395
Align Technology
ALGN
$12.4B
| $229M | 0.05% |
4,091,885
+250,456
| +7% | +$13.2M |
|
|
GWR
396
DELISTED
Genesee & Wyoming Inc.
GWR
| $227M | 0.05% |
2,528,708
-9,100
| -0.4% | -$841K |
|
397
Regency Centers
REG
$13.9B
| $227M | 0.05% |
3,553,625
+653
| +0% | +$39.4K |
|
398
Kroger
KR
$34.3B
| $226M | 0.05% |
7,053,830
-930,760
| -12% | -$26.9M |
|
|
MKTO
399
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $226M | 0.05% |
6,902,905
+259,504
| +4% | +$8.18M |
|
400
Shutterstock
SSTK
$208M
| $225M | 0.05% |
3,259,644
+316,488
| +11% | +$23M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.